MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Mesenchymal stem cell research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,627 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,627 works in the cohort · of 4,299,418page 12 of 33

Labels cover 1 of 1,627 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,627 of 1,627 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Cell technologies for spinal fusion
Francis H. Shen, Dino Samartzis, Howard S. An
2005· review· en· The Spine Journal· Medicine
distilled prediction:candidate · noneconsensus · none
32
citations
affunlabeled
Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee
Kevin P. Robb, Jacques Galipeau, Yufang Shi, M. Schuster, Iván Martín, Sowmya Viswanathan
2023· article· en· Cytotherapy· Medicine
distilled prediction:candidate · metaepi_narrow+scholarly_communicationconsensus · none
31
citations
affunlabeled
Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval—FASTER Approval
Aidan M. Kirkham, Adrian Bailey, Madeline Monaghan, Risa Shorr, Manoj M. Lalu, Dean Fergusson +1 more
2022· review· en· Stem Cells Translational Medicine· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+metaepi_broad+insufficient_payloadconsensus · metaresearch
31
citations
← previousnext →

How this was built: Screen · Findings · About